Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer
Go back to Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer| FLEXION THERAPEUT (NYSE: FLXN) | Delayed: 24.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.62 | 52 Week High | $23.57 | |||
| Open | $24.62 | 52 Week Low | $7.56 | |||
| Day High | $24.62 | P/E | N/A | |||
| Day Low | $24.62 | EPS | $-2.04 | |||
| Volume | 3 | |||||
